Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
Cancers · 27.01.2023 · 15 (3) · 777
DOI: 10.3390/cancers15030777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.01.2023. Verfasst von Anne Knisely und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, T32 gynecologic oncology training, T32 surgical oncology training.
Abstract (Originalsprache)
The gut microbiome comprises a diverse array of microbial species that have been shown to dynamically modulate host immunity both locally and systemically, as well as contribute to tumorigenesis. In this review, we discuss the scientific evidence on the role that gut microbes and diet play in response and toxicity to cancer treatment. We highlight studies across multiple cancer cohorts that have shown an association between particular gut microbiome signatures and an improved response to immune checkpoint blockade, chemotherapy, and adoptive cell therapies, as well as the role of particular microbes in driving treatment-related toxicity and how the microbiome can be modulated through strategies, such as fecal transplant. We also summarize the current literature that implicate high fiber and ketogenic diets in improved response rates to immunotherapy and chemotherapy, respectively. Finally, we discuss the relevance of these findings in the context of patient care, advocate for a holistic approach to cancer treatment, and comment on the next frontier of targeted gut and tumor microbiome modulation through novel therapeutics, dietary intervention, and precision-medicine approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Anne Knisely, Manoj Chelvanambi
Förderung
- NCI NIH HHS
- T32 gynecologic oncology training
- T32 surgical oncology training
Zitieren
APA
Knisely, A., Seo, Y. D., Wargo, J. A., & Chelvanambi, M. (2023). Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers, 15(3), 777. https://doi.org/10.3390/cancers15030777
Vancouver
Knisely A, Seo YD, Wargo JA, Chelvanambi M. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers. 2023;15(3):777. doi:10.3390/cancers15030777
BibTeX
@article{Knisely2023,
author = {Knisely, Anne and Seo, Yongwoo David and Wargo, Jennifer A and Chelvanambi, Manoj},
title = {Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {777},
doi = {10.3390/cancers15030777}
}
EUVIMED